| Primary |
| Anaesthesia |
16.3% |
| Musculoskeletal Pain |
13.3% |
| Spinal Anaesthesia |
9.0% |
| Local Anaesthesia |
8.6% |
| Pain |
7.7% |
| Epidural Anaesthesia |
7.2% |
| Postoperative Analgesia |
7.0% |
| Nerve Block |
4.1% |
| General Anaesthesia |
3.6% |
| Caesarean Section |
2.9% |
| Cataract Operation |
2.7% |
| Analgesia |
2.5% |
| Pain Management |
2.5% |
| Maintenance Of Anaesthesia |
2.3% |
| Back Pain |
2.0% |
| Sedation |
2.0% |
| Hypertension |
1.8% |
| Induction Of Anaesthesia |
1.8% |
| Analgesic Therapy |
1.4% |
| Myocardial Ischaemia |
1.4% |
|
| Hearing Impaired |
16.9% |
| Musculoskeletal Pain |
15.4% |
| Drug Ineffective |
10.0% |
| Pain |
6.2% |
| Chondrolysis |
4.6% |
| Post Procedural Complication |
4.6% |
| Unresponsive To Stimuli |
4.6% |
| Convulsion |
3.8% |
| Myocardial Ischaemia |
3.8% |
| Ventricular Fibrillation |
3.8% |
| Diplopia |
3.1% |
| Horner's Syndrome |
3.1% |
| Pharmaceutical Product Complaint |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Anaesthetic Complication |
2.3% |
| Arthralgia |
2.3% |
| Myoclonus |
2.3% |
| Neuromuscular Block Prolonged |
2.3% |
| Paraesthesia |
2.3% |
| Paraplegia |
2.3% |
|
| Secondary |
| Pain |
20.6% |
| Spinal Anaesthesia |
13.2% |
| Anaesthesia |
6.3% |
| Product Used For Unknown Indication |
5.8% |
| Epidural Anaesthesia |
5.8% |
| Local Anaesthesia |
5.5% |
| Cancer Pain |
5.5% |
| Postoperative Analgesia |
5.2% |
| Drug Use For Unknown Indication |
4.7% |
| Hyperlipidaemia |
4.3% |
| Hypertension |
4.0% |
| Back Pain |
2.7% |
| Procedural Pain |
2.5% |
| Dehydration |
2.5% |
| Foetal Exposure During Pregnancy |
2.4% |
| Caesarean Section |
2.1% |
| General Anaesthesia |
1.8% |
| Postoperative Care |
1.8% |
| Analgesia |
1.6% |
| Epidural Analgesia |
1.6% |
|
| Hypotension |
20.9% |
| Vertigo |
10.3% |
| Visual Acuity Reduced |
7.2% |
| Disseminated Intravascular Coagulation |
6.2% |
| Vomiting |
6.2% |
| Convulsion |
5.5% |
| Pain |
4.5% |
| Muscular Weakness |
4.1% |
| Myoclonus |
4.1% |
| Parophthalmia |
3.8% |
| Procedural Hypotension |
3.8% |
| Respiratory Failure |
3.4% |
| Chondrolysis |
3.1% |
| Tachycardia |
2.7% |
| Anaphylactic Reaction |
2.4% |
| Drug Ineffective |
2.4% |
| Heart Rate Decreased |
2.4% |
| Paraplegia |
2.4% |
| Spinal Cord Infarction |
2.4% |
| Unresponsive To Stimuli |
2.4% |
|
| Concomitant |
| Muscle Spasticity |
17.9% |
| Pain |
13.0% |
| Anaesthesia |
12.9% |
| Drug Use For Unknown Indication |
9.5% |
| Product Used For Unknown Indication |
7.8% |
| Spinal Anaesthesia |
5.0% |
| Hypertension |
3.9% |
| Epidural Anaesthesia |
3.5% |
| General Anaesthesia |
3.1% |
| Analgesic Effect |
2.9% |
| Procedural Pain |
2.8% |
| Prophylaxis |
2.7% |
| Pain Management |
2.5% |
| Postoperative Analgesia |
2.3% |
| Analgesia |
2.1% |
| Cancer Pain |
1.6% |
| Maintenance Of Anaesthesia |
1.6% |
| Neuralgia |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Thrombosis Prophylaxis |
1.5% |
|
| Pain |
12.9% |
| Vomiting |
11.8% |
| Cancer Pain |
11.4% |
| Death |
9.3% |
| Somnolence |
6.4% |
| Malaise |
6.1% |
| Pneumonia |
4.3% |
| Unresponsive To Stimuli |
3.9% |
| Tachycardia |
3.6% |
| Withdrawal Syndrome |
3.6% |
| Device Malfunction |
3.2% |
| Respiratory Failure |
3.2% |
| Anaesthetic Complication Neurological |
2.9% |
| Hypotension |
2.9% |
| Sedation |
2.9% |
| Paraesthesia |
2.5% |
| Tremor |
2.5% |
| Weight Decreased |
2.5% |
| Drug Ineffective |
2.1% |
| Vascular Resistance Systemic Decreased |
2.1% |
|
| Interacting |
| Nerve Block |
31.6% |
| Analgesic Therapy |
15.8% |
| Antibiotic Therapy |
15.8% |
| Abdominal Pain |
7.9% |
| Analgesic Effect |
7.9% |
| Restlessness |
7.9% |
| Spinal Anaesthesia |
5.3% |
| Antibiotic Prophylaxis |
2.6% |
| Pain |
2.6% |
| Product Used For Unknown Indication |
2.6% |
|
| Toxicity To Various Agents |
50.0% |
| Hypotension |
16.7% |
| Myoclonus |
16.7% |
| Talipes |
16.7% |
|
